Your browser doesn't support javascript.
loading
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial.
Seymour, John F; Byrd, John C; Ghia, Paolo; Kater, Arnon P; Chanan-Khan, Asher; Furman, Richard R; O'Brien, Susan; Brown, Jennifer R; Munir, Talha; Mato, Anthony; Stilgenbauer, Stephan; Bajwa, Naghmana; Miranda, Paulo; Higgins, Kara; John, Ellie; de Borja, Marianne; Jurczak, Wojciech; Woyach, Jennifer A.
Afiliación
  • Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
  • Byrd JC; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Ghia P; Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
  • Kater AP; Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Chanan-Khan A; Mayo Clinic Jacksonville, Jacksonville, FL.
  • Furman RR; Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY.
  • O'Brien S; Chao Family Comprehensive Cancer Center, University of California-Irvine, Irvine, CA.
  • Brown JR; Dana-Farber Cancer Institute, Boston, MA.
  • Munir T; Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom.
  • Mato A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Stilgenbauer S; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Bajwa N; AstraZeneca, Gaithersburg, MD.
  • Miranda P; AstraZeneca, Gaithersburg, MD.
  • Higgins K; AstraZeneca, South San Francisco, CA.
  • John E; AstraZeneca, Cambridge, United Kingdom.
  • de Borja M; AstraZeneca, Mississauga, ON, Canada.
  • Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.
  • Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Blood ; 142(8): 687-699, 2023 08 24.
Article en En | MEDLINE | ID: mdl-37390310

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Leucemia Linfocítica Crónica de Células B / Hipertensión Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Leucemia Linfocítica Crónica de Células B / Hipertensión Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Australia